Pain and Opioids: Integrated Treatment In Veterans (POSITIVE)
Chronic Pain, Opioid-use Disorder, Opioids; Harmful Use
About this trial
This is an interventional treatment trial for Chronic Pain
Eligibility Criteria
Inclusion Criteria:
- Stabilized on a dose of buprenorphine for a period of at least 1 month and less than six months. Buprenorphine stabilization will be defined as a consistent dose for at least 30 consecutive days.
- Willing to comply with all study procedures and be available for the duration of the study
- Male or female, aged 21 to 75 years.
- Enrolled as a patient in one of the participating VA Co-Occurring Disorders clinics.
- Presence of chronic pain for > 6 months in duration.
Exclusion Criteria:
- Current or past diagnosis of schizophrenia, delusional disorder, psychotic or dissociative disorders.
- Unable to read English.
- Have a substance use disorder requiring a higher level of care than outpatient treatment (e.g., severe alcohol use disorder requiring inpatient detoxification).
Sites / Locations
- San Francisco VA Health Care SystemRecruiting
- New Mexico VA Healthcare SystemRecruiting
- University of New Mexico
- Puget Sound VA Healthcare SystemRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
ACT + MBRP
Education Control (EC)
Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention (ACT + MBRP) group will follow a manualized clinical protocol. Treatment will include 12 weekly group-based sessions, each lasting 90 minutes. Group sizes will range from 3 to 8. ACT + MBRP will be delivered via the VA Video Connect telehealth platform.
The EC group will follow a protocol that combines opioid education sessions and psychology-led pain education sessions that are offered as part of the interdisciplinary pain program. Specifically, education will include 12 group-based sessions, each lasting 60 to 90 minutes. Group sizes will range from 3 to 8. EC will be delivered via the VA Video Connect telehealth platform.